X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Aarti Pharmalabs Ltd.
BSE CODE: 543748   |   NSE CODE: AARTIPHARM   |   ISIN CODE : INE0LRU01027   |   15-Sep-2025 Hrs IST
BSE NSE
Rs. 939.80
13.25 ( 1.43% )
 
Prev Close ( Rs.)
926.55
Open ( Rs.)
934.65
 
High ( Rs.)
942.80
Low ( Rs.)
913.95
 
Volume
33725
Week Avg.Volume
20263
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 939.50
13.15 ( 1.42% )
 
Prev Close ( Rs.)
926.35
Open ( Rs.)
928.70
 
High ( Rs.)
943.05
Low ( Rs.)
913.85
 
Volume
274241
Week Avg.Volume
212039
 
52 WK High-Low Range(Rs.)
557.05
971
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)28.39  22.14  18.95  4269.05  -0.18  
   CEPS(Rs)37.12  29.42  25.10  5758.37  -0.18  
   DPS(Rs)5.00  3.00  2.00  0.00  0.00  
   Book NAV/Share(Rs)203.25  178.89  158.74  49558.52  9.12  
   Tax Rate(%)23.49  26.91  26.41  20.19  0.00  
Margin Ratios          
   Core EBITDA Margin(%)24.08  23.04  20.40  19.11  0  
   EBIT Margin(%)20.43  19.38  16.80  15.42  0  
   Pre Tax Margin(%)18.99  18.28  15.44  14.21  0  
   PAT Margin (%)14.53  13.36  11.36  11.34  0  
   Cash Profit Margin (%)18.99  17.75  15.05  15.30  0  
Performance Ratios          
   ROA(%)10.25  9.39  9.03  11.68  -1.84  
   ROE(%)14.86  13.11  12.83  17.23  -2.00  
   ROCE(%)17.61  16.55  15.60  18.03  -1.93  
   Asset Turnover(x)0.71  0.70  0.79  1.03  0.00  
   Sales/Fixed Asset(x)1.13  1.08  1.26  0.85  0  
   Working Capital/Sales(x)3.00  2.60  3.01  2.30  0.00  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.88  0.92  0.80  1.17  0  
   Receivable days103.17  99.68  81.62  118.00  0  
   Inventory Days116.05  136.05  118.59  172.36  0  
   Payable days104.56  113.41  76.78  53.18  0  
Valuation Parameters          
   PER(x)26.36  19.65  14.49  0.00  0.00  
   PCE(x)20.17  14.78  10.94  0.00  0.00  
   Price/Book(x)3.68  2.43  1.73  0.00  0.00  
   Yield(%)0.67  0.69  0.73  0  0  
   EV/Net Sales(x)4.05  2.79  1.78  0.29  0  
   EV/Core EBITDA(x)16.27  11.73  8.71  1.47  -3.76  
   EV/EBIT(x)19.82  14.39  10.62  1.85  -3.76  
   EV/CE(x)3.21  2.24  1.64  0.17  0.07  
   M Cap / Sales3.83  2.62  1.65  0.00  0  
Growth Ratio          
   Net Sales Growth(%)17.92  -0.60  60.60  0  0  
   Core EBITDA Growth(%)23.48  15.36  69.84  0.00  75.37  
   EBIT Growth(%)24.32  14.70  74.99  0.00  75.37  
   PAT Growth(%)28.26  16.84  60.90  0.00  75.37  
   EPS Growth(%)28.25  16.84  -99.56  0.00  75.37  
Financial Stability Ratios          
   Total Debt/Equity(x)0.21  0.15  0.14  0.26  0.08  
   Current Ratio(x)1.95  2.04  2.08  1.85  11.42  
   Quick Ratio(x)1.07  0.99  0.92  0.93  11.42  
   Interest Cover(x)14.12  17.50  12.39  12.79  0  
   Total Debt/Mcap(x)0.06  0.06  0.08  0  0